Shikonin Promotes Skin Cell Proliferation and Inhibits Nuclear Factor-κB Translocation via Proteasome Inhibition In Vitro.

Authors:
Yan Yan
Yan Yan
First Affiliated Hospital
China
Minao Furumura
Minao Furumura
Kurume University School of Medicine
Atsufumi Iwanaga
Atsufumi Iwanaga
School of Pharmaceutical Sciences
Kwesi Teye
Kwesi Teye
Kurume University School of Medicine
Japan
Sanae Numata
Sanae Numata
Kurume University School of Medicine
Tadashi Karashima
Tadashi Karashima
Kurume University School of Medicine
Japan
Xiao-Guang Li
Xiao-Guang Li
Peking Union Medical College Hospital
China

Chin Med J (Engl) 2015 Aug;128(16):2228-33

Department of Dermatology, Kurume University School of Medicine, Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka 830-0011, Japan.

Background: Shikonin is a major active chemical component extracted from Lithospermi Radix, an effective traditional herb in various types of wound healing. Shikonin can accelerate granulomatous tissue formation by the rat cotton pellet method and induce neovascularization in granulomatous tissue. The purpose of the study was to investigate its mechanism of action in human skin cells.

Methods: MTS assay was used to measure cell growth. The collagen type I (COL1 ) mRNA expression and procollagen type I C-peptide (PIP) production were detected by real-time quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Immunofluorescence and western blot analyses were carried out to investigate nuclear factor-κB (NF-κB) signaling pathway. Cell-based proteasome activity assay was used to determine proteasome activity.

Results: In this study, we found that 10 μmol/L shikonin stimulated the growth of normal human keratinocytes and 1 μmol/L shikonin promoted growth of human dermal fibroblasts. However, shikonin did not directly induce COL1 mRNA expression and PIP production in dermal fibroblasts in vitro. In addition, 1 μmol/L shikonin inhibited translocation of NF-κB p65 from cytoplasm to nucleus induced by tumor necrosis factor-α stimulation in dermal fibroblasts. Furthermore, shikonin inhibited chymotrypsin-like activity of proteasome and was associated with accumulation of phosphorylated inhibitor κB-α in dermal fibroblasts.

Conclusions: These results suggested that shikonin may promote wound healing via its cell growth promoting activity and suppress skin inflammation via inhibitory activity on proteasome. Thus, shikonin may be a potential therapeutic reagent both in wound healing and inflammatory skin diseases.

Download full-text PDF

Source
http://dx.doi.org/10.4103/0366-6999.162512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717985PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
August 2015
15 Reads

Publication Analysis

Top Keywords

dermal fibroblasts
12
μmol/l shikonin
12
wound healing
12
shikonin
10
granulomatous tissue
8
nuclear factor-κb
8
shikonin inhibited
8
col1 mrna
8
cell growth
8
fibroblasts shikonin
8
activity proteasome
8
pip production
8
mrna expression
8
proteasome
5
immunosorbent assay
4
reaction enzyme-linked
4
enzyme-linked immunosorbent
4
associated accumulation
4
assay immunofluorescence
4
proteasome associated
4

Similar Publications